Alzheimer’s Society comment on the announcement of human trials of cannabis-derived drugs
Published 11 March 2008
The quest for treatments for people with dementia is a critical area of research.
There are encouraging findings from studies with animals suggesting that some cannabis derivatives may help protect nerve cells in the brain. We therefore look forward to robust clinical trials into potential benefits of non-psychoactive components of cannabis. It is important for people to note that these treatments are not same as recreational cannabis use which can be potentially harmful.
Professor Clive Ballard
Director of research